Noticias de CYDY_US

Noticias del mercado

Últimas noticias sobre CYDY_US — 68 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CYDY_US ✕ 68 resultados
23/04/2026 CYDY_US — CytoDyn Inc.
CytoDyn to Host Investor Webcast
22/04/2026 CYDY_US — Stocktwits
CYDY Stock Falls Despite Positive Cancer Study Data – Retail Says CytoDyn Is ‘Here To Stay’
22/04/2026 CYDY_US — CytoDyn Inc. ES ← EN
CytoDyn presenta nuevos datos de leronlimab en cáncer colorrectal metastásico en la reunión anual de la AACR 2026

CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026

22/04/2026 CYDY_US — CytoDyn Inc.
CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026
22/04/2026 CYDY_US — The Manila Times
CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026
22/04/2026 CYDY_US — The Manila Times
CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study
22/04/2026 CYDY_US — Stock Titan
CytoDyn (CYDY) files S-1 to register 278M shares for selling stockholders
22/04/2026 CYDY_US — Stock Titan
For hard-to-treat colorectal cancer, CytoDyn combo shows 70% tumor DNA drop
21/04/2026 CYDY_US — CytoDyn Inc. ES ← EN
CytoDyn completa la inscripción en el estudio de fase 2 sobre cáncer colorrectal metastásico
21/04/2026 CYDY_US — CytoDyn Inc.
CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study
21/04/2026 CYDY_US — Stock Titan
CytoDyn fills 60-patient colorectal cancer trial across 7 U.S. sites
20/04/2026 CYDY_US — CytoDyn Inc. ES ← EN
CytoDyn presenta nuevos datos de leronlimab en cáncer de mama metastásico triple negativo en la reunión anual de la AACR 2026

CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026

20/04/2026 CYDY_US — The Manila Times
CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026
20/04/2026 CYDY_US — CytoDyn Inc.
CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026
20/04/2026 CYDY_US — Stock Titan
Breast cancer study ties CytoDyn drug to 5-year survival in some patients
14/04/2026 CYDY_US — The Manila Times
CytoDyn to Present at the AACR Annual Meeting 2026
14/04/2026 CYDY_US — CytoDyn Inc.
CytoDyn to Present at the AACR Annual Meeting 2026
14/04/2026 CYDY_US — Stock Titan
Two leronlimab cancer studies put CytoDyn on the AACR 2026 agenda
13/04/2026 CYDY_US — ADVFN ES ← EN
Formulario 10-Q - Informe trimestral [Secciones 13 o 15(d)]
08/04/2026 CYDY_US — Stock Titan
CytoDyn Inc. (CYDY) registers 375.999M shares; 49M shares tied to settlement

Página 2 de 4

keyboard_arrow_up